what are the ash 2022 takeaways for aml patients?
Published 1 year ago • 16 plays • Length 3:16Download video MP4
Download video MP3
Similar videos
-
4:36
expert advice for aml patients when making treatment choices
-
2:11
assessing untreated aml patients who are ineligible for intensive chemotherapy
-
4:53
individualized approach to treating aml patients | pamela becker, md, phd | ash 2022 #aml
-
1:59
how is an aml treatment approach determined?
-
2:39
what are the goals of aml treatment?
-
4:57
ash 2022: talquetamab showing promise in multiple myeloma clinical trial
-
35:37
leukemias - dr. hossam mowafy
-
11:17
car-t cells: engineered cancer killers
-
4:12
what promising aml treatments are available for newly diagnosed patients?
-
3:10
choosing an aml treatment path: what should you consider?
-
4:50
aml targeted therapies, what’s available and how do they work?
-
4:43
what are the latest acute myeloid leukemia therapies?
-
3:22
aml treatment approaches expand for older and high-risk patients
-
3:46
a look at lower intensity chemotherapy in untreated aml
-
4:12
what does triplet therapy in aml mean for the future?
-
2:42
which tests do you need before deciding on an aml treatment path?
-
33:20
aml treatment decisions: what’s right for you?
-
3:29
what different aml subtypes are more prevalent in certain demographics?
-
3:10
venetoclax and azacitidine in newly diagnosed aml patients | dan pollyea, md, ms | ash 2022 #aml
-
53:48
emerging research and promising aml treatment approaches
-
3:51
what are the different types of aml? #aml
-
2:43
what treatments are on the horizon for acute myeloid leukemia patients